We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$136B
AUM Growth
+$19.8B
Cap. Flow
+$10.6B
Cap. Flow %
7.76%
Top 10 Hldgs %
11.1%
Holding
5,079
New
591
Increased
1,620
Reduced
1,625
Closed
731

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$964M
2
AAPL icon
Apple
AAPL
+$606M
3
WDAY icon
Workday
WDAY
+$520M
4
PLTR icon
Palantir
PLTR
+$514M
5
SPOT icon
Spotify
SPOT
+$431M

Sector Composition

Rank Sector Weight
1 Technology 13.54%
2 Consumer Discretionary 8.87%
3 Healthcare 8.21%
4 Financials 5.68%
5 Industrials 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLI
4026
Standard Lithium
SLI
$517M
$99.2K ﹤0.01%
67,957
-17,734
-21% -$32.6K
RNWWW
4027
ReNew Energy Global PLC Warrant
RNWWW
$59.3K
$96.5K ﹤0.01%
591,955
CKPT
4028
DELISTED
Checkpoint Therapeutics
CKPT
$95K ﹤0.01%
29,695
-58,727
-66% -$199K
AMPX.WS icon
4029
Amprius Technologies Warrants
AMPX.WS
$360M
$94.8K ﹤0.01%
+267,000
New +$55K
BFLY.WS
4030
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$91.9K ﹤0.01%
723,004
HCAT icon
4031
Health Catalyst
HCAT
$154M
$91.7K ﹤0.01%
12,965
-79,341
-86% -$632K
RVNC
4032
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$91.2K ﹤0.01%
30,000
NVTS icon
4033
Navitas Semiconductor
NVTS
$2.66B
$90.1K ﹤0.01%
+25,241
New +$70.2K
WW
4034
PUT
DELISTED
WW International
WW
$89.2K ﹤0.01%
70,200
ENGNW icon
4035
enGene Therapeutics Warrants
ENGNW
$3.75M
$88.9K ﹤0.01%
104,622
URG
4036
Ur-Energy
URG
$485M
$85.8K ﹤0.01%
+74,601
New +$92K
BACQR
4037
DELISTED
Inflection Point Acquisition Corp IV Right
BACQR
$85K ﹤0.01%
+500,000
New +$88.3K
APPS icon
4038
PUT
Digital Turbine
APPS
$1.02B
$84.5K ﹤0.01%
50,000
FUFUW icon
4039
BitFuFu Inc Warrant
FUFUW
$82.5K ﹤0.01%
150,000
MRNOW
4040
Murano Global Investments PLC Warrants
MRNOW
$224K
$82.5K ﹤0.01%
375,000
GRND.WS
4041
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$81.7K ﹤0.01%
12,097
AG icon
4042
PUT
First Majestic Silver
AG
$8.05B
$78.5K ﹤0.01%
+14,300
New +$92.3K
WGSWW
4043
DELISTED
GeneDx Holdings Warrant
WGSWW
$74.8K ﹤0.01%
467,197
CHPT icon
4044
ChargePoint
CHPT
$133M
$74.7K ﹤0.01%
3,492
SLSR
4045
Solaris Resources
SLSR
$1.28B
$73.5K ﹤0.01%
23,700
+11,400
+93% +$30.8K
NG icon
4046
NovaGold Resources
NG
$2.6B
$73.5K ﹤0.01%
+22,061
New +$78K
CCIXW
4047
Churchill Capital Corp IX Warrant
CCIXW
$71.9K
$73.2K ﹤0.01%
175,000
OLMA icon
4048
Olema Pharmaceuticals
OLMA
$1.02B
$72.6K ﹤0.01%
12,445
-13,148
-51% -$131K
MITT
4049
TPG Mortgage Investment Trust
MITT
$230M
$70.3K ﹤0.01%
+10,566
New +$74.8K
AZUL
4050
DELISTED
Azul
AZUL
$68.4K ﹤0.01%
+40,974
New +$107K

Similar funds

D.E. Shaw & Co's Q4 2024 Portfolio in Review

As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.

  • D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
  • D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
  • D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
  • D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
  • D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
  • D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.